GlassScriptPhysician profile
Kerry Shuffelbottom
NPI 1902102676
$6,949.58
in general payments reported to CMS, 2019-2025
9 companies · $71.37 in 2025
The $71.37 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $1,539 · 2023: $4,471 · 2024: $501 · 2025: $71.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,594 · Food and Beverage: $2,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,594.29 |
| Food and Beverage | $2,449.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,249.05 | 2021-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,265.25 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.12 | 2022-2024 | Relistor |
| Abbvie INC. | $94.83 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $65.18 | 2023-2024 | Belbuca |
| Forte Bio-Pharma LLC | $47.64 | 2023-2024 | Prolate, Nalocet |
| Ibsa Pharma INC. | $33.19 | 2023-2024 | Tirosint, Licart, Tirosint |
| Nevro Corp. | $18.18 | 2024 | Senza |
| Nuvasive, INC. | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Shuffelbottom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.